CORT - CORCEPT THERAPEUTICS INC

QQQ $ 472.93 $ -0.50 (-0.11 %)

DIA $ 411.97 $ 2.70 (0.66 %)

SPY $ 560.27 $ 0.00 (0 %)

TLT $ 100.12 $ -0.47 (-0.47 %)

GLD $ 237.77 $ 0.18 (0.08 %)

Previous Close

$ 35.71

Open

Bid

-- x --

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 20.84 - $ 39.75

Volume

417,402

Average Volume

Market Cap

3.73B

Beta (5Y Monthly)

$ 0.38

PE Ratio (TTM)

$ 29.86

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	07-29-2024	06-30-2024	10-Q
2	05-01-2024	03-31-2024	10-Q
3	02-15-2024	12-31-2023	10-K
4	11-01-2023	09-30-2023	10-Q
5	08-02-2023	06-30-2023	10-Q
6	05-03-2023	03-31-2023	10-Q
7	02-28-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-03-2022	06-30-2022	10-Q
10	05-05-2022	03-31-2022	10-Q
11	02-15-2022	12-31-2021	10-K
12	11-03-2021	09-30-2021	10-Q
13	07-29-2021	06-30-2021	10-Q
14	05-06-2021	03-31-2021	10-Q
15	02-23-2021	12-31-2020	10-K
16	11-03-2020	09-30-2020	10-Q
17	08-04-2020	06-30-2020	10-Q
18	05-04-2020	03-31-2020	10-Q
19	02-24-2020	12-31-2019	10-K
20	11-07-2019	09-30-2019	10-Q
21	08-01-2019	06-30-2019	10-Q
22	05-09-2019	03-31-2019	10-Q
23	02-26-2019	12-31-2018	10-K
24	11-02-2018	09-30-2018	10-Q
25	08-09-2018	06-30-2018	10-Q
26	05-09-2018	03-31-2018	10-Q
27	02-28-2018	12-31-2017	10-K
28	11-03-2017	09-30-2017	10-Q
29	08-02-2017	06-30-2017	10-Q
30	05-02-2017	03-31-2017	10-Q
31	03-06-2017	12-31-2016	10-K
32	11-02-2016	09-30-2016	10-Q
33	08-03-2016	06-30-2016	10-Q
34	05-04-2016	03-31-2016	10-Q
35	03-10-2016	12-31-2015	10-K
36	11-06-2015	09-30-2015	10-Q
37	08-07-2015	06-30-2015	10-Q
38	05-08-2015	03-31-2015	10-Q
39	03-13-2015	12-31-2014	10-K
40	11-07-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Canaccord Genuity Maintains Buy on Corcept...
07/31/2024 12:33:19

Canaccord Genuity analyst Edward Nash maintains Corcept Therapeutics (NASDAQ:CORT) with a Buy and raises the price target fr...

Canaccord Genuity Maintains Buy on Corcept...
07/30/2024 15:28:33

Canaccord Genuity analyst Edward Nash maintains Corcept Therapeutics (NASDAQ:CORT) with a Buy and maintains $38 price target.

Unveiling 8 Analyst Insights On Corcept Th...
07/30/2024 12:00:32

Corcept Therapeutics shares are trading hi...
07/30/2024 11:45:17

Piper Sandler Maintains Overweight on Corc...
07/30/2024 11:19:19

Piper Sandler analyst David Amsellem maintains Corcept Therapeutics (NASDAQ:CORT) with a Overweight and raises the price tar...

HC Wainwright & Co. Maintains Buy on Corce...
07/30/2024 10:40:11

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Corcept Therapeutics (NASDAQ:CORT) with a Buy and raises th...

Corcept Therapeutics Raises 2024 Revenue G...
07/29/2024 20:13:16

Corcept Therapeutics Q2 2024 GAAP EPS $0.3...
07/29/2024 20:12:09

Corcept Therapeutics (NASDAQ:CORT) reported quarterly earnings of $0.32 per share which beat the analyst consensus estimate of ...

Piper Sandler Reiterates Overweight on Cor...
07/01/2024 13:44:13

Piper Sandler analyst David Amsellem reiterates Corcept Therapeutics (NASDAQ:CORT) with a Overweight and maintains $35 price...

Corcept Therapeutics Announces Results Fro...
06/24/2024 20:16:59

Results from the CATALYST clinical trial were presented at the American Diabetes Association's 84th Scientific Sessions at ...

6 Analysts Have This To Say About Corcept ...
06/17/2024 19:00:59

Truist Securities Maintains Buy on Corcept...
06/17/2024 15:27:39

Truist Securities analyst Joon Lee maintains Corcept Therapeutics (NASDAQ:CORT) with a Buy and maintains $65 price target.

concerpt-therapeutics-shares-are-trading-lower-what-you-need-to-know

Concerpt Therapeutics Shares Are Trading L...
06/14/2024 18:54:41

Corcept Therapeutics Inc. (NASDAQ: CORT) shares are trading lower Friday afternoon following a report suggesting Teva Pharmaceu...

why-ammo-shares-are-trading-lower-by-over-19-here-are-other-stocks-moving-in-fridays-mid-day-session

Why AMMO Shares Are Trading Lower By Over ...
06/14/2024 18:13:08

Reported Late Thursday: Teva Sues Corcept ...
06/14/2024 16:31:28

Teva sues Corcept over mifepristone 'monopoly' for rare disorder | Reuters

Truist Securities Reiterates Buy on Corcep...
06/04/2024 13:22:01

Truist Securities analyst Joon Lee reiterates Corcept Therapeutics (NASDAQ:CORT) with a Buy and raises the price target from...

10-health-care-stocks-with-whale-alerts-in-todays-session

10 Health Care Stocks With Whale Alerts In...
06/03/2024 17:35:22

Corcept Therapeutics To Present Results Of...
06/03/2024 12:36:13

Corcept Therapeutics Incorporated (NASDAQ:CORT), a commercial-stage company engaged in the discovery and development of medicat...

Corcept Therapeutics Stock: A Deep Dive In...
05/29/2024 13:00:44

HC Wainwright & Co. Reiterates Buy on Corc...
05/29/2024 10:56:34

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Corcept Therapeutics (NASDAQ:CORT) with a Buy and maintain...